This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of David Yellen
Introduction
David Yellen is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of tuberous sclerosis complex (TSC). His innovative work has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
David Yellen holds 1 patent for his invention titled "Gene therapy for tuberous sclerosis." This invention provides compositions and methods for treating TSC. Specifically, it includes condensed tuberins (cTuberins), cTuberin nucleic acids, and recombinant adeno-associated viruses (rAAVs) that carry a cTuberin nucleic acid for treating patients with TSC.
Career Highlights
Yellen is associated with The General Hospital Corporation, where he continues to advance his research and innovations. His work in gene therapy showcases his commitment to addressing complex medical challenges through scientific innovation.
Collaborations
David Yellen has collaborated with esteemed colleagues such as Xandra O Breakefield and Casey Maguire. These partnerships enhance the research and development of his innovative therapies.
Conclusion
David Yellen's contributions to gene therapy represent a significant advancement in the treatment of tuberous sclerosis. His dedication to innovation and collaboration in the medical field is commendable and holds promise for future breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile